Egr-1 upregulates the Alzheimer's disease presenilin-2 gene in neuronal cells

Gene

Volumn 318, Issue 1-2, 2003, Pages 113-124

  Renbaum, Paul ^a   Beeri, Rachel ^a   Gabai, Efrat ^a,b   Amiel, Merav ^a,b   Gal, Moran ^a,b   Ehrengruber, Markus U ^c   Levy Lahad, Ephrat ^a,b,d  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY   (Israel)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d Medical   (Israel)

Author keywords

5 UTR; Alzheimer's disease; Egr 1; Presenilin 2; Promoter; Sp1; Transcriptional regulation

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; PHORBOL 13 ACETATE 12 MYRISTATE; PRESENILIN 2; TRANSCRIPTION FACTOR SP1;

ALZHEIMER DISEASE; ARTICLE; CELL LINE; CONTROLLED STUDY; EMBRYO; EXON; GENE CONTROL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; KIDNEY CELL; NERVE CELL; NERVE CELL PLASTICITY; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; UPREGULATION;

TRIXIS;

EID: 0242317327     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(03)00766-2     Document Type: Article

References (30)

1. Alves D.C., Paitel E., Mattson M.P., Amson R., Telerman A., Ancolio K., Checler F. Wild-type and mutated presenilins 2 trigger p53-dependent apoptosis and down-regulate presenilin 1 expression in HEK293 human cells and in murine neurons. Proc. Natl. Acad. Sci. U. S. A. 99:2002;4043-4048.
2. Catania M.V., Copani A., Calogero A., Ragonese G.I., Condorelli D.F., Nicoletti F. An enhanced expression of the immediate early gene, Egr-1, is associated with neuronal apoptosis in culture. Neuroscience. 91:1999;1529-1538.
3. Charron M., Shaper J.H., Shaper N.L. The increased level of beta1, 4-galactosyltransferase required for lactose biosynthesis is achieved in part by translational control. Proc. Natl. Acad. Sci. U. S. A. 95:1998;14805-14810.
4. Culvenor J.G., Evin G., Cooney M.A., Wardan H., Sharples R.A., Maher F., Reed G., Diehlmann A., Weidemann A., Beyreuther K., Masters C.L. Presenilin 2 expression in neuronal cells: induction during differentiation of embryonic carcinoma cells. Exp. Cell Res. 255:2000;192-206.
5. Deng G., Su J.H., Cotman C.W. Gene expression of Alzheimer-associated presenilin-2 in the frontal cortex of Alzheimer and aged control brain. FEBS Lett. 394:1996;17-20.
6. Desjardins S., Mayo W., Vallee M., Hancock D., Le Moal M., Simon H., Abrous D.N. Effect of aging on the basal expression of c-Fos, c-Jun, and Egr-1 proteins in the hippocampus. Neurobiol. Aging. 18:1997;37-44.
7. Dignam J.D., Lebovitz R.M., Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489.
8. Ehrengruber M.U., Muhlebach S.G., Söhrman S., Leutenegger C.M., Lester H.A., Davidson N. Modulation of early growth response (EGR) transcription factor-dependent gene expression by using recombinant adenovirus. Gene. 258:2000;63-69.
9. Huang R.P., Fan Y., Ni Z., Mercola D., Adamson E.D. Reciprocal modulation between Sp1 and Egr-1. J. Cell. Biochem. 66:1997;489-499.
10. Johnston J.A., Froelich S., Lannfelt L., Cowburn R.F. Quantification of presenilin-1 mRNA in Alzheimer's disease brains. FEBS Lett. 394:1996;279-284.
11. Kozak M. Do the 5′ untranslated domains of human cDNAs challenge the rules for initiation of translation (or is it vice versa)? Genomics. 70:2000;396-406.
12. Levy-Lahad E., Poorkaj P., Wang K., Fu Y.H., Oshima J., Mulligan J., Schellenberg G.D. Genomic structure and expression of STM2, the chromosome 1 familial Alzheimer disease gene. Genomics. 34:1996;198-204.
13. Lukiw W.J., Gordon W.C., Rogaev E.I., Thompson H., Bazan N.G. Presenilin-2 (PS2) expression upregulation in a model of retinopathy of prematurity and pathoangiogenesis. NeuroReport. 12:2001;53-57.
14. McCoy C., Smith D.E., Cornwell M.M. 12-O-tetradecanoylphorbol-13-acetate activation of the MDR1 promoter is mediated by EGR1. Mol. Cell. Biol. 15:1995;6100-6108.
15. McMillan P.J., Leverenz J.B., Dorsa D.M. Specific downregulation of presenilin 2 gene expression is prominent during early stages of sporadic late-onset Alzheimer's disease. Brain Res. Mol. Brain Res. 78:2000;138-145.
16. Mitsuda N., Ohkubo N., Tamatani M., Lee Y.D., Taniguchi M., Namikawa K., Kiyama H., Yamaguchi A., Sato N., Sakata K., Ogihara T., Vitek M.P., Tohyama M. Activated cAMP-response element-binding protein regulates neuronal expression of presenilin-1. J. Biol. Chem. 276:2001;9688-9698.
17. Nishiyama K., Murayama S., Suzuki T., Mitsui Y., Sakaki Y., Kanazawa I. Presenilin 1 mRNA expression in hippocampi of sporadic Alzheimer's disease patients. Neurosci. Res. 26:1996;75-78.
18. O'Donovan K.J., Tourtellotte W.G., Millbrandt J., Baraban J.M. The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience. Trends Neurosci. 22:1999;167-173.
19. Pastorcic M., Das H.K. Regulation of transcription of the human presenilin-1 gene by ets transcription factors and the p53 protooncogene. J. Biol. Chem. 275:2000;34938-34945.
20. Pennypacker K.R., Fuldner R., Xu R., Hernandez H., Dawbarn D., Mehta N., Perez-Tur J., Baker M., Hutton M. Cloning and characterization of the presenilin-2 gene promoter. Brain Res. Mol. Brain Res. 56:1998;57-65.
21. Quandt K., Frech K., Karas H., Wingender E., Werner T. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23:1995;4878-4884.
22. Roperch J.P., Alvaro V., Prieur S., Tuynder M., Nemani M., Lethrosne F., Piouffre L., Gendron M.C., Israeli D., Dausset J., Oren M., Amson R., Telerman A. Inhibition of presenilin 1 expression is promoted by p53 and p21WAF-1 and results in apoptosis and tumor suppression. Nat. Med. 4:1998;835-838.
23. Satoh J., Kuroda Y. Constitutive and cytokine-regulated expression of presenilin-1 and presenilin-2 genes in human neural cell lines. Neuropathol. Appl. Neurobiol. 25:1999;492-503.
24. Scherf M., Klingenhoff A., Werner T. Highly specific localization of promoter regions in large genomic sequences by PromoterInspector: a novel context analysis approach. J. Mol. Biol. 297:2000;599-606.
25. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81:2001;741-766.
26. Takami K., Terai K., Matsuo A., Walker D.G., McGeer P.L. Expression of presenilin-1 and -2 mRNAs in rat and Alzheimer's disease brains. Brain Res. 748:1997;122-130.
27. Theuns J., Van Broeckhoven C. Transcriptional regulation of Alzheimer's disease genes: implications for susceptibility. Hum. Mol. Genet. 9:2000;2383-2394.
28. Theuns J., Del-Favero J., Dermaut B., van Duijn C.M., Backhovens H., Van den Broeck M.V., Serneels S., Corsmit E., Van Broeckhoven C.V., Cruts M. Genetic variability in the regulatory region of presenilin 1 associated with risk for Alzheimer's disease and variable expression. Hum. Mol. Genet. 9:2000;325-331.
29. Tischmeyer W., Grimm R. Activation of immediate early genes and memory formation. Cell. Mol. Life Sci. 55:1999;564-574.
30. Wei X., Zhang Y., Zhou J. Alzheimer's disease-related gene expression in the brain of senescence accelerated mouse. Neurosci. Lett. 268:1999;139-142.